Drug Trial Radar · NCT01522456
Split-face Tolerability Comparison Between Adapalene-Benzoyl Peroxide Gel Versus Tretinoin Gel
Last checked: Nov 20, 2026Latest source record: Aug 1, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
73
Actual
Start
Apr 2012
Primary completion
May 2012
Study completion May 2012
Sponsor
- Lead sponsor
- Galderma R&DIndustry
- Sponsor type
- Industry
- First posted
- Jan 31, 2012
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To compare the tolerability of Epiduo® (adapalene and benzoyl peroxide) Gel 0.1%/2.5% to Retin-A Micro® (tretinoin gel) microsphere when used by subjects with acne vulgaris for 3 weeks in terms of local tolerability parameters (erythema, dryness, scaling, stinging/burning) and preference.
Conditions
- Acne Vulgaris
Interventions
Epiduo GelDrug
Once-daily application of fixed dose of adapalene 0.1% and benzoyl peroxide 2.5% in an aqueous based gel.
Retin-A Micro Microsphere 0.1%Drug
Once-daily application of tretinoin gel, 0.1% by weight, in a formulation of porous microspheres in an aqueous gel.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Worst Postbaseline Tolerability (Erythema)Time frame: Day 1 - Day 22
- Worst Postbaseline Tolerability (Scaling)Time frame: Day 1 - Day 22
- Worst Postbaseline Tolerability (Dryness)Time frame: Day 1 - Day 22
- Worst Postbaseline Tolerability (Stinging/Burning)Time frame: Day 1 - Day 22
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Stephens and Associates
Dallas, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.